8-KThe WireStrategic
Exit / Disposal Costs · Reg FD Disclosure
Filed Jun 29, 2026 · 1d ago · Accession 0001171843-26-004333
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- BIOCRYST PHARMACEUTICALS INC
- Ticker
- BCRX
- CIK
- 882796
- Form type
- 8-K
- Filing date
- Jun 29, 2026
- Report date
- Jun 25, 2026
- Document
- f8k_062926.htm
- Size
- 235 KB